Physician

Gabriel Elia, MD

According to 2025 Medicare claims, Gabriel Elia, MD (NPI: 1528107547) practices nephrology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is EDWARD W SPARROW HOSPITAL ASSOCIATION (NPI: 1568867190; TIN: 381360584) and primary practice location at 48912-1811. Elia is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Elia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 324 traditional Medicare patients, billed 1,402 HCPCS/CPT codes, and received $144,835 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,515 prescription claims across 309 beneficiaries totaling $333,286 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 12 claims. Open Payments data shows 35 records totaling $723. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $290,219 to $144,835. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $323,919 to $333,286. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,074 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$145K$290K2015 Medicare payment: $290,219 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $256,617 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $257,631 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $282,751 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $264,810 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $222,021 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $221,262 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $161,824 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $166,597 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $144,835 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159478,743$290,219
20168496,311$256,617
20177714,114$257,631
20189243,904$282,751
20197262,806$264,810
20205022,186$222,021
20215042,009$221,262
20223781,585$161,824
20233431,342$166,597
20243241,402$144,835

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$370K$741K2015 Drug cost: $323,919 (USD; Tot_Drug_Cst)2016 Drug cost: $740,526 (USD; Tot_Drug_Cst)2017 Drug cost: $523,918 (USD; Tot_Drug_Cst)2018 Drug cost: $424,514 (USD; Tot_Drug_Cst)2019 Drug cost: $364,410 (USD; Tot_Drug_Cst)2020 Drug cost: $292,035 (USD; Tot_Drug_Cst)2021 Drug cost: $230,209 (USD; Tot_Drug_Cst)2022 Drug cost: $232,339 (USD; Tot_Drug_Cst)2023 Drug cost: $286,733 (USD; Tot_Drug_Cst)2024 Drug cost: $333,286 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152341,233$323,919
20163481,765$740,526
20173121,617$523,918
20182721,272$424,514
20192711,340$364,410
20202461,193$292,035
20212471,125$230,209
20222411,035$232,339
20232721,172$286,733
20243091,515$333,286

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$9.6K$19K2015 Medicare payment: $2,341 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $16,567 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $19,289 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $11,389 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,741 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,874 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,988 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $288 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R48$2,341
201626258$16,567
201735296$19,289
2018N/R249$11,389
2019N/R206$5,741
2020N/R114$3,874
2021N/R131$3,230
2022N/R94$1,988
2023N/RN/RN/R
2024N/R12$288

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes6169$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more106170$64
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes93262$58
99231Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes5479$37
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's115177$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FarxigaDapagliflozin Propanediol564,620$89,505
VelphoroSucroferric Oxyhydroxide16720$51,579
AuryxiaFerric Citrate261,025$45,197
JardianceEmpagliflozin301,980$38,504
OzempicSemaglutide13364$11,839

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7507Tacrolimus, immediate release, oral, 1 mgNN/R12$288

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$723OPKO Pharmaceuticals, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gabriel Elia, MD?

Tedicare shows public-source Medicare data for Gabriel Elia, MD (NPI 1528107547), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gabriel Elia, MD have ACO affiliation data?

Gabriel Elia, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Gabriel Elia, MD?

Gabriel Elia, MD is linked to EDWARD W SPARROW HOSPITAL ASSOCIATION (billing NPI 1568867190) in the available physician profile data.

Does Gabriel Elia, MD have Open Payments data?

Gabriel Elia, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.